X4 Pharmaceuticals, Inc.
CXCR4 inhibitors and uses thereof

Last updated:

Abstract:

The present invention provides compounds, compositions thereof, and methods of using the same.

Status:
Grant
Type:

Utility

Filling date:

21 Jun 2017

Issue date:

17 May 2022